Pal et al. show that in CD44+/CD24- cells from a human lung cancer cell line, TGF-β decreased the activity of genes responsible for accurately fixing breaks in the CD44+/CD24- cells’ DNA. This evidence concerns the gene CD44 and lung carcinoma.